{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:32:26Z","timestamp":1789439546151,"version":"build-2803163510"},"reference-count":32,"publisher":"American Chemical Society (ACS)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2017,12,28]]},"DOI":"10.1021\/acs.jmedchem.7b01044","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T16:23:28Z","timestamp":1512404608000},"page":"10026-10046","source":"Crossref","is-referenced-by-count":22,"title":["Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases"],"prefix":"10.1021","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-1526","authenticated-orcid":true,"given":"Laura","family":"Carzaniga","sequence":"first","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Amari","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rizzi","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelida","family":"Capaldi","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"De Fanti","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Ghidini","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Villetti","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Carnini","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Moretto","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Facchinetti","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Caruso","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gessica","family":"Marchini","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Battipaglia","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Patacchini","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cenacchi","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Volta","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Amadei","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Pappani","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Capacchi","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bagnacani","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Delcanale","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Puccini","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Catinella","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Civelli","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Armani","sequence":"additional","affiliation":[{"name":"Chemistry Research and Drug Design, \u2225Pharmacology and Toxicology, \u2021Pharmacokinetics Biochemistry and Metabolism, \u2020Analytics and Early Formulations, #Project Leader Corporate Drug Development, and \u22a5Corporate Pre-Clinical R&D Director, Chiesi Farmaceutici S.p.A, Nuovo Centro Ricerche, Largo Belloli 11\/a, 43122 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2017,12,14]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-17969-3_2"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2010.03.011"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666151117121334"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.297"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02640.x"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S7667"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X10381432"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.1.109"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704457"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S89849"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0303-8"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.12.008"},{"key":"ref13\/cit13","first-page":"1149","volume":"6","author":"Gutke H. J.","year":"2005","journal-title":"Curr. Opin. Investig. Drugs."},{"key":"ref14\/cit14","first-page":"A131","volume":"175","author":"Danto S.","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00068908"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.173690"},{"key":"ref17\/cit17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.114.220558","volume":"352","author":"Nials A. T.","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.220541"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.220558"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2016.06.011"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1021\/jm5001216"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.08.056"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1021\/jm401549m"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2004.10.004"},{"issue":"22","key":"ref25\/cit25","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.1016\/S0021-9258(19)86536-5","volume":"254","author":"Baehr W.","year":"1979","journal-title":"J. Biol. Chem."},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1021\/bi00778a018"},{"key":"ref27\/cit27","volume-title":"Maestro","year":"2011"},{"key":"ref28\/cit28","volume-title":"LigPrep","year":"2011"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-007-9133-z"},{"key":"ref30\/cit30","volume-title":"Glide","year":"2011"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1107\/S0021889807021206"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444996012255"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.7b01044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:11:28Z","timestamp":1682122288000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.7b01044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":32,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,12,28]]}},"alternative-id":["10.1021\/acs.jmedchem.7b01044"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01044","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,14]]}}}